RemSleep Holdings (RMSL) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.89% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.35% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 14.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.56% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.46% |
| 10 | RemSleep Holdings | - | - | -7,636.00 | -48.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -48.03% |
| Sep 30, 2025 | -52.52% |
| Jun 30, 2025 | -53.77% |
| Mar 31, 2025 | -55.49% |
| Dec 31, 2024 | -59.56% |
| Sep 30, 2024 | -49.12% |
| Jun 30, 2024 | -41.07% |
| Mar 31, 2024 | -36.91% |
| Dec 31, 2023 | 32.29% |
| Sep 30, 2023 | 106.68% |
| Jun 30, 2023 | 91.80% |
| Mar 31, 2023 | 116.56% |
| Dec 31, 2022 | 31.33% |
| Sep 30, 2022 | 9.77% |
| Jun 30, 2022 | 32.21% |
| Mar 31, 2022 | 13.22% |
| Dec 31, 2021 | 10.16% |
| Sep 30, 2021 | -14.28% |
| Jun 30, 2021 | -23.81% |
| Mar 31, 2021 | -3.85% |
| Dec 31, 2020 | -11.54% |
| Sep 30, 2020 | 46.60% |
| Jun 30, 2020 | 80.97% |
| Mar 31, 2020 | 69.36% |
| Dec 31, 2019 | 180.50% |
| Sep 30, 2019 | 127.97% |
| Jun 30, 2019 | 343.62% |
| Mar 31, 2019 | 671.94% |
| Dec 31, 2018 | 352.93% |
| Sep 30, 2018 | 259.10% |
| Jun 30, 2018 | 13.85% |
| Mar 31, 2018 | -36.83% |
| Dec 31, 2017 | -33.94% |
| Sep 30, 2017 | -31.15% |
| Jun 30, 2017 | -6.89% |
| Mar 31, 2017 | -6.78% |
| Dec 31, 2016 | -6.66% |
| Sep 30, 2016 | -6.53% |
| Jun 30, 2016 | -7.91% |
| Mar 31, 2016 | -6.32% |
| Dec 31, 2015 | 216.80% |